A Single Center, Open-label, Randomized Comparative Study to Evaluate the Effect of Aliskiren on Myocardial Perfusion Reserve and Coronary Flow Reserve in Hypertensive Patients with a history of Myocardial Infarction
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 17 May 2016
At a glance
- Drugs Aliskiren; Antihypertensives
- Indications Cardiovascular disorders; Hypertension
- Focus Therapeutic Use
- 30 May 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 06 Oct 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 02 May 2011 New trial record